One of the major obstacles limiting the effectiveness of chemotherapeutic programmes is the inability of the present drug inventory to discriminate normal from malignant neoplastic tissue. As the search for selective anticancer drugs has been largely ineffective to date, considerable research effort has been directed toward the development of drug carrier systems1. One of the systems being investigated are closed vesicles composed primarily of phospholipids2,3. Liposomes have been extensively used as models3,4 for biological membrane research and have contributed to understanding the physico-chemical properties of biological membranes6,7. They have also advanced our understanding of cell-cell recognition8,9, fusion10,11 and protein-lipid interaction12,13. The self-assembly properties of phospholipid amphiphiles make possible the entrapment of water soluble compounds within the aqueous lumen of the liposome14. It became evident that entrapment of enzymes within liposomes might provide a therapeutic vehicle useful in treatment of diseases of enzyme deficiency15,16.
Water Soluble Compound Liposome Preparation Small Unilamellar Vesicle Local Hyperthermia Unilamellar Liposome
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access
M.B. Yatvin, J.N. Weinstein, W.H. Dennis, and R. Blumenthal, Design of liposomes for enhanced local release of drugs by hyperthermia, Science, 202: 1290 (1978).PubMedCrossRefGoogle Scholar
J.N. Weinstein, R.L. Magin, M.B. Yatvin, and D.S. Zaharko, Liposomes and local hyperthermia: selective delivery of methotrexate to heated tumors, Science, 204: 188 (1979).PubMedCrossRefGoogle Scholar
J.N. Weinstein, R.L. Magin, R.L. Cysyk, and D.S. Zaharko, Treatment of solid L1210 murine tumors with local hyperthermia and temperature-sensitive liposomes containing methotrexate, Cancer Res., 40: 1388 (1980).PubMedGoogle Scholar
M.B. Yatvin, W. Kreutz, B.A. Horwitz and M. Shinitzky, pH-Sensitive liposomes: possible clinical implications, Science 210: 1253 (1980).Google Scholar
H.K. Kimelberg, Differential distribution of liposome-entrapped 3H-methotrexate and labelled lipids after intravenous injection in a primate, Biochim. Biophys. Acta, 448: 531 (1976).PubMedCrossRefGoogle Scholar
G. Scherphof, F. Roerdink, M. Waite, and J. Parks, Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins, Biochim. Biophys. Acta, 542: 196 (1978).CrossRefGoogle Scholar
G. Scherphof, H. Morselt, J. Regts, and J.C. Wilschut, The involvement of the lipid phase transition in the plasma-induced dissolution of multilamellar phosphatidylcholine vesicles, Biochim. Biophys. Acta, 556: 196 (1979).CrossRefGoogle Scholar
G. Scherphof, The role of the liver in the clearance of liposomes from the blood, second WCCC international workshop on experimental oncology, Madison, Wisconsin (1981), Abs. 22.Google Scholar
M.B. Yatvin, H. Muhlensiepen, W. Porshcen, J.N. Weinstein, and L.E. Feinendegen, Selective delivery of liposome-associated cis-dichlorodiammineplatinum (II) by heat and its influence on tumor drug uptake and growth, Cancer Res., 41: 1602 (1981).PubMedGoogle Scholar
A. Watts, D. Marsh, and P.F. Knowles, Characterization of dimyristoyl phosphatidylcholine vesicles and their dimensional changes through the phase transition: molecular control of membrane morphology, Biochemistry, 17: 1792 (1978).PubMedCrossRefGoogle Scholar
P.M. Gullino, H. Grantham, S.H. Smith, and A.C. Haggerty, Modification of the acid-base status of the internal milieu of tumors, J. Natl. Cancer Inst., 34: 857 (1965).PubMedGoogle Scholar